Evidence map›Paper›PMID 38271611›Full record

ArticleJournal of the American Society for Mass Spectrometry2024

Weighting Low-Intensity MS/MS Ions and

Chloe Engler Hart, Tobias Kind, Pieter C Dorrestein, David Healey, Daniel Domingo-Fernández

Abstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chloe Engler HartEnveda Biosciences, 5700 Flatiron Parkway, Boulder, Colorado 80301, United States.
Tobias KindEnveda Biosciences, 5700 Flatiron Parkway, Boulder, Colorado 80301, United States.ORCID 0000-0002-1908-4916
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California 92093, United States.ORCID 0000-0002-3003-1030
David HealeyEnveda Biosciences, 5700 Flatiron Parkway, Boulder, Colorado 80301, United States.
Daniel Domingo-FernándezEnveda Biosciences, 5700 Flatiron Parkway, Boulder, Colorado 80301, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calculating spectral similarity is a fundamental step in MS/MS data analysis in untargeted metabolomics experiments, as it facilitates the identification of related spectra and the annotation of compounds. To improve matching accuracy when querying an experimental mass spectrum against a spectral library, previous approaches have proposed increasing peak intensities for high

Indexed as

MetabolomicsTandem Mass SpectrometryIonsIons

Identifiers

PMID38271611
PMCPMC10854760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.